Covered recipient · General Payments record
AWAB KAMAL MAHMOUD ELNAEEM
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2024
$841.67
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $494.73 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $176.42 | 1 |
| ABBVIE INC. | $110.83 | 5 |
| CHIESI USA, INC. | $99.96 | 1 |
| SK Life Science, Inc. | $33.17 | 1 |
| ARGENX US, INC. | $29.37 | 1 |
| Neurelis, Inc. | $26.58 | 1 |
| Acorda Therapeutics, Inc | $18.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $176.42 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125106684 | CMS |
| ABBVIE INC. | $16.94 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103689704 | CMS |
| ABBVIE INC. | $16.15 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103689706 | CMS |
| ABBVIE INC. | $28.37 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103689708 | CMS |
| ABBVIE INC. | $24.90 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103689710 | CMS |
| ABBVIE INC. | $24.47 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103689712 | CMS |
| Acorda Therapeutics, Inc | $18.40 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142347742 | CMS |
| ARGENX US, INC. | $29.37 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142127251 | CMS |
| Chiesi USA, Inc. | $99.96 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151805633 | CMS |
| Neurelis, Inc. | $26.58 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145640800 | CMS |
| SK Life Science, Inc. | $33.17 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154144178 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.